Connection

Prabhakar Baliga to Cytomegalovirus Infections

This is a "connection" page, showing publications Prabhakar Baliga has written about Cytomegalovirus Infections.
Connection Strength

0.475
  1. Viruses in posttransplant thrombotic microangiopathy. Transplantation. 2001 Aug 27; 72(4):750.
    View in: PubMed
    Score: 0.175
  2. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200?days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.135
  3. Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk? Transplantation. 2010 May 27; 89(10):1218-23.
    View in: PubMed
    Score: 0.080
  4. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9.
    View in: PubMed
    Score: 0.054
  5. Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient. Transplant Proc. 1995 Oct; 27(5 Suppl 1):42-3.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.